An expert explains the basics of von Hippel-Lindau—related kidney cancer, and how a new drug for the disease is shaping the way patients are treated. Patients with von Hippel-Lindau (VHL) disease are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback